| Cotransplantation of human mesenchymal stem cells enhances human myelopoiesis and megakaryocytopoiesis in NOD/SCID mice M Angelopoulou, E Novelli, JE Grove, HM Rinder, C Civin, L Cheng, ... Experimental hematology 31 (5), 413-420, 2003 | 291 | 2003 |
| Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients PL Zinzani, M Martelli, M Bertini, AM Gianni, L Devizzi, M Federico, ... haematologica 87 (12), 1258-1264, 2002 | 244 | 2002 |
| Prognostic value of serum free light chain ratio at diagnosis in multiple myeloma MC Kyrtsonis, TP Vassilakopoulos, N Kafasi, S Sachanas, T Tzenou, ... British journal of haematology 137 (3), 240-243, 2007 | 203 | 2007 |
| Durable clinical, cytogenetic, and molecular remissions after allogeneic hematopoietic cell transplantation for refractory Sezary syndrome and mycosis fungoides A Molina, J Zain, DA Arber, M Angelopolou, M O’Donnell, ... Journal of clinical oncology 23 (25), 6163-6171, 2005 | 148 | 2005 |
| CD20 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin’s disease: associations with presenting features and clinical outcome GZ Rassidakis, LJ Medeiros, S Viviani, V Bonfante, GP Nadali, ... Journal of Clinical Oncology 20 (5), 1278-1287, 2002 | 148 | 2002 |
| BCL-2 expression in Hodgkin and Reed-Sternberg cells of classical Hodgkin disease predicts a poorer prognosis in patients treated with ABVD or equivalent regimens GZ Rassidakis, LJ Medeiros, TP Vassilakopoulos, S Viviani, V Bonfante, ... Blood, The Journal of the American Society of Hematology 100 (12), 3935-3941, 2002 | 140 | 2002 |
| Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone with or without radiotherapy in primary mediastinal large B-cell lymphoma: the emerging standard of care TP Vassilakopoulos, GA Pangalis, A Katsigiannis, SG Papageorgiou, ... The oncologist 17 (2), 239-249, 2012 | 138 | 2012 |
| B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic … GA Pangalis, MK Angelopoulou, TP Vassilakopoulos, MP Siakantaris, ... Seminars in hematology 36 (2), 104-114, 1999 | 138 | 1999 |
| A prospective, cohort, multicentre study of candidaemia in hospitalized adult patients with haematological malignancies MN Gamaletsou, TJ Walsh, T Zaoutis, M Pagoni, M Kotsopoulou, ... Clinical Microbiology and Infection 20 (1), O50-O57, 2014 | 121 | 2014 |
| Acute lymphoplasmacytoid dendritic cell (DC2) leukemia: results from the Hellenic Dendritic Cell Leukemia Study Group NJ Tsagarakis, NA Kentrou, KA Papadimitriou, M Pagoni, G Kokkini, ... Leukemia research 34 (4), 438-446, 2010 | 119 | 2010 |
| Rituximab monotherapy is highly effective in splenic marginal zone lymphoma C Kalpadakis, GA Pangalis, MN Dimopoulou, TP Vassilakopoulos, ... Hematological oncology 25 (3), 127-131, 2007 | 118 | 2007 |
| Treatment of splenic marginal zone lymphoma with rituximab monotherapy: progress report and comparison with splenectomy C Kalpadakis, GA Pangalis, MK Angelopoulou, S Sachanas, ... The Oncologist 18 (2), 190-197, 2013 | 101 | 2013 |
| Waldenström's macroglobulinemia: clinical course and prognostic factors in 60 patients: Experience from a single hematology unit MC Kyrtsonis, T Vassilakopoulos, M Angelopoulou, M Siakantaris, ... Annals of hematology 80, 722-727, 2001 | 100 | 2001 |
| Frequent NFKBIE deletions are associated with poor outcome in primary mediastinal B-cell lymphoma L Mansouri, D Noerenberg, E Young, E Mylonas, M Abdulla, M Frick, ... Blood, The Journal of the American Society of Hematology 128 (23), 2666-2670, 2016 | 98 | 2016 |
| Clonal B-cell lymphocytosis exhibiting immunophenotypic features consistent with a marginal-zone origin: is this a distinct entity? A Xochelli, C Kalpadakis, A Gardiner, P Baliakas, TP Vassilakopoulos, ... Blood, The Journal of the American Society of Hematology 123 (8), 1199-1206, 2014 | 95 | 2014 |
| Campath-1H (anti-CD52) monoclonal antibody therapy in lymphoproliferative disorders: A review GA Pangalis, MN Dimopoulou, MK Angelopoulou, C Tsekouras, ... Medical Oncology 18, 99-107, 2001 | 91 | 2001 |
| Serum interleukin-10 levels are an independent prognostic factor for patients with Hodgkin's lymphoma TP Vassilakopoulos, G Nadali, MK Angelopoulou, MP Siakantaris, ... haematologica 86 (3), 274-281, 2001 | 90 | 2001 |
| Angiogenesis in Hodgkin's lymphoma: a morphometric approach in 286 patients with prognostic implications P Korkolopoulou, I Thymara, N Kavantzas, TP Vassilakopoulos, ... Leukemia 19 (6), 894-900, 2005 | 83 | 2005 |
| B‐chronic lymphocytic leukemia: practical aspects GA Pangalis, TP Vassilakopoulos, MN Dimopoulou, MP Siakantaris, ... Hematological oncology 20 (3), 103-146, 2002 | 81 | 2002 |
| Adhesion molecules in B-chronic lymphoproliferative disorders. MK Angelopoulou, FN Kontopidou, GA Pangalis Seminars in hematology 36 (2), 178-197, 1999 | 79 | 1999 |
